Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LobSor Holding AB
DescriptionGel formulation of levodopa, carbidopa and entacapone for continuous intestinal administration by an ambulatory pump system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today